Jump Financial, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Jump Financial, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$146.51 - $198.2 $1.5 Million - $2.03 Million	10,262 Added 140.73%	17,554 $2.62 Million
Q4 2023 Oct 21, 2024	SELL	$151.41 - $196.57 $173,667 - $225,465	-1,147 Reduced 13.59%	7,292 $1.4 Million
Q4 2023 Feb 07, 2024	BUY	$151.41 - $196.57 $1.1 Million - $1.43 Million	7,292 New	7,292 $1.4 Million
Q2 2023 Oct 21, 2024	SELL	$185.01 - $212.05 $3.95 Million - $4.52 Million	-21,337 Reduced 71.66%	8,439 $1.6 Million
Q2 2023 Aug 07, 2023	SELL	$185.01 - $212.05 $3.95 Million - $4.52 Million	-21,337 Reduced 71.66%	8,439 $1.6 Million
Q1 2023 Oct 21, 2024	BUY	$182.66 - $235.53 $5.44 Million - $7.01 Million	29,776 New	29,776 $5.96 Million
Q1 2023 May 03, 2023	BUY	$182.66 - $235.53 $4.34 Million - $5.59 Million	23,748 Added 393.96%	29,776 $5.96 Million
Q4 2022 Feb 13, 2023	BUY	$185.53 - $241.31 $872,733 - $1.14 Million	4,704 Added 355.29%	6,028 $1.43 Million
Q3 2022 Nov 07, 2022	BUY	$138.54 - $232.0 $183,426 - $307,168	1,324 New	1,324 $265,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $28.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.